ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.

Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T, Viscoli C, Herbrecht R

Open source

DOI
10.3324/haematol.2016.152900
Published
2017 Mar
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2016.152900,
  title = {ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.},
  author = {Tissot F and Agrawal S and Pagano L and Petrikkos G and Groll AH and Skiada A and Lass-Flörl C and Calandra T and Viscoli C and Herbrecht R},
  year = {2017},
  journal = {Haematologica},
  doi = {10.3324/haematol.2016.152900},
  url = {https://doi.org/10.3324/haematol.2016.152900}
}

RIS

TY  - JOUR
TI  - ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.
AU  - Tissot F
AU  - Agrawal S
AU  - Pagano L
AU  - Petrikkos G
AU  - Groll AH
AU  - Skiada A
AU  - Lass-Flörl C
AU  - Calandra T
AU  - Viscoli C
AU  - Herbrecht R
PY  - 2017
JO  - Haematologica
DO  - 10.3324/haematol.2016.152900
UR  - https://doi.org/10.3324/haematol.2016.152900
ER  - 

APA

F, T., S, A., L, P., G, P., AH, G., A, S., C, L., T, C., C, V., & R, H. (2017). ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.. Haematologica. https://doi.org/10.3324/haematol.2016.152900

Source records